Results

Extended release nevirapine QD in treatment-naïve (VERxVE study)

A randomised, double blind, double dummy, parallel group, active controlled trial to evaluate the antiviral efficacy of 400 mg QD neVirapine Extended Release formulation in comparison to 200 mg BID neVirapinE immediate release in combination with Truvada™ in antiretroviral therapy naïve HIV-1 infected patients. (VERxVE study)(Trial number 1100.1486)

Learn More

Results

ARIES Study

Atazanavir + Ritonavir + Abacavir/Lamivudine combination in HIV-1 infection

Learn More

Completed

TMC125 Expanded access programme

Early access of TMC125 in combination with other antiretrovirals in treatment-experienced HIV-1 infected subjects with limited treatment options (TMC125-C214)

Learn More